Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 25,669 | 18,641 | 12,100 | 0 | 0 |
| Cost of Goods | 2,629 | 3,953 | N/A | N/A | N/A |
| Gross Profit | 23,040 | 14,688 | 12,100 | N/A | N/A |
| Operating Expenses | 99,720 | 192,034 | 69,210 | 55,381 | 40,619 |
| Operating Income | -76,051 | -176,393 | -57,110 | -55,381 | -40,619 |
| Interest Expense | 11,918 | 10,544 | 3,131 | 542 | 17 |
| Other Income | 13,699 | -506 | -16,134 | -21,449 | -16,792 |
| Pre-tax Income | -74,270 | -187,443 | -76,375 | -77,372 | -57,428 |
| Net Income Continuous | -74,270 | -187,443 | -76,375 | -77,372 | -57,428 |
| Net Income Discontinuous | N/A | N/A | 577 | -90 | -10,178 |
| Net Income | $-74,270 | $-187,443 | $-75,798 | $-77,462 | $-67,606 |
| EPS Basic Total Ops | -1.08 | -2.91 | -1.22 | -1.45 | -1.65 |
| EPS Basic Continuous Ops | -1.08 | -2.91 | -1.23 | -1.45 | -1.40 |
| EPS Basic Discontinuous Ops | N/A | N/A | 0.01 | 0.00 | -0.25 |
| EPS Diluted Total Ops | -1.08 | -2.91 | -1.22 | -1.45 | -1.65 |
| EPS Diluted Continuous Ops | -1.08 | -2.91 | -1.23 | -1.45 | -1.40 |
| EPS Diluted Discontinuous Ops | N/A | N/A | 0.01 | 0.00 | -0.25 |
| EBITDA(a) | $-66,303 | $-163,114 | $-47,363 | $-46,601 | $-33,615 |